Tizanidine
NDC 70518-0133, Tizanidine, tablet, from REMEDYREPACK INC..
- Product NDC
- 70518-0133
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076286
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0133 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIZANIDINE HYDROCHLORIDE4 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-0133-0 | 70518013300 | 60 TABLET in 1 BOTTLE (70518-0133-0) |
| 70518-0133-1 | 70518013301 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-0133-1) |
| 70518-0133-3 | 70518013303 | 30 TABLET in 1 BOTTLE, PLASTIC (70518-0133-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/59084f59-9a9b-49f0-a9f4-27f3eab9a228
Use it
Look up 70518-0133 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0133 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-0133. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.